BioAtla, Inc. (BCAB)
NASDAQ·Healthcare·Biotechnology
$3.61
+4.63%
Mkt Cap $5.31M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$250.00
Range $250.00 – $250.00
Implied Upside
+6825.4%
Consensus $250.00 vs current $3.61
NASDAQ·Healthcare·Biotechnology
$3.61
+4.63%
Mkt Cap $5.31M
No recent rating data.
Price Target (1 analysts)
$250.00
Range $250.00 – $250.00
+6825.4%
Consensus $250.00 vs current $3.61